Literature DB >> 28507022

Loss of E-Cadherin-Dependent Cell-Cell Adhesion and the Development and Progression of Cancer.

Heather C Bruner1, Patrick W B Derksen2.   

Abstract

Classical cadherins are the key molecules that control cell-cell adhesion. Notwithstanding this function, it is also clear that classical cadherins are more than just the "glue" that keeps the cells together. Cadherins are essential regulators of tissue homeostasis that govern multiple facets of cellular function and development, by transducing adhesive signals to a complex network of signaling effectors and transcriptional programs. In cancer, cadherins are often inactivated or functionally inhibited, resulting in disease development and/or progression. This review focuses on E-cadherin and its causal role in the development and progression of breast and gastric cancer. We provide a summary of the biochemical consequences and consider the conceptual impact of early (mutational) E-cadherin loss in cancer. We advocate that carcinomas driven by E-cadherin loss should be considered "actin-diseases," caused by the specific disruption of the E-cadherin-actin connection and a subsequent dependence on sustained actomyosin contraction for tumor progression. Based on the available data from mouse and human studies we discuss opportunities for targeted clinical intervention.
Copyright © 2018 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28507022      PMCID: PMC5830899          DOI: 10.1101/cshperspect.a029330

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  171 in total

1.  Plakoglobin and beta-catenin: distinct but closely related.

Authors:  S Butz; J Stappert; H Weissig; R Kemler
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

2.  DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis.

Authors:  Y-J Chen; J T Chang; L Lee; H-M Wang; C-T Liao; C-C Chiu; P-J Chen; A-J Cheng
Journal:  Oncogene       Date:  2006-07-31       Impact factor: 9.867

3.  Loss of p120 catenin and links to mitotic alterations, inflammation, and skin cancer.

Authors:  Mirna Perez-Moreno; Weimin Song; H Amalia Pasolli; Scott E Williams; Elaine Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-22       Impact factor: 11.205

4.  Restraining FOXO3-dependent transcriptional BMF activation underpins tumour growth and metastasis of E-cadherin-negative breast cancer.

Authors:  M Hornsveld; M Tenhagen; R A van de Ven; A M M Smits; M H van Triest; M van Amersfoort; D E A Kloet; T B Dansen; B M Burgering; P W B Derksen
Journal:  Cell Death Differ       Date:  2016-04-01       Impact factor: 15.828

5.  Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.

Authors:  Patrick W B Derksen; Xiaoling Liu; Francis Saridin; Hanneke van der Gulden; John Zevenhoven; Bastiaan Evers; Judy R van Beijnum; Arjan W Griffioen; Jacqueline Vink; Paul Krimpenfort; Johannes L Peterse; Robert D Cardiff; Anton Berns; Jos Jonkers
Journal:  Cancer Cell       Date:  2006-11       Impact factor: 31.743

6.  Non-canonical Wnt signals are modulated by the Kaiso transcriptional repressor and p120-catenin.

Authors:  Si Wan Kim; Jae-Il Park; Christopher M Spring; Amy K Sater; Hong Ji; Abena A Otchere; Juliet M Daniel; Pierre D McCrea
Journal:  Nat Cell Biol       Date:  2004-11-14       Impact factor: 28.824

7.  Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis.

Authors:  R C Humphreys; M Krajewska; S Krnacik; R Jaeger; H Weiher; S Krajewski; J C Reed; J M Rosen
Journal:  Development       Date:  1996-12       Impact factor: 6.868

8.  A novel role for p120 catenin in E-cadherin function.

Authors:  Renee C Ireton; Michael A Davis; Jolanda van Hengel; Deborah J Mariner; Kirk Barnes; Molly A Thoreson; Panos Z Anastasiadis; Linsey Matrisian; Linda M Bundy; Linda Sealy; Barbara Gilbert; Frans van Roy; Albert B Reynolds
Journal:  J Cell Biol       Date:  2002-11-11       Impact factor: 10.539

9.  p120-Catenin Is Critical for the Development of Invasive Lobular Carcinoma in Mice.

Authors:  Milou Tenhagen; Sjoerd Klarenbeek; Tanya M Braumuller; Ilse Hofmann; Petra van der Groep; Natalie Ter Hoeve; Elsken van der Wall; Jos Jonkers; Patrick W B Derksen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2016-07-13       Impact factor: 2.673

10.  An essential role for p120-catenin in Src- and Rac1-mediated anchorage-independent cell growth.

Authors:  Michael R Dohn; Meredith V Brown; Albert B Reynolds
Journal:  J Cell Biol       Date:  2009-02-02       Impact factor: 10.539

View more
  47 in total

1.  Functional characterization of recurrent FOXA2 mutations seen in endometrial cancers.

Authors:  Robert Neff; Craig M Rush; Blair Smith; Floor J Backes; David E Cohn; Paul J Goodfellow
Journal:  Int J Cancer       Date:  2018-09-29       Impact factor: 7.396

2.  Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants.

Authors:  Kristy Lee; Kate Krempely; Maegan E Roberts; Michael J Anderson; Fatima Carneiro; Elizabeth Chao; Katherine Dixon; Joana Figueiredo; Rajarshi Ghosh; David Huntsman; Pardeep Kaurah; Chimene Kesserwan; Tyler Landrith; Shuwei Li; Arjen R Mensenkamp; Carla Oliveira; Carolina Pardo; Tina Pesaran; Matthew Richardson; Thomas P Slavin; Amanda B Spurdle; Mackenzie Trapp; Leora Witkowski; Charles S Yi; Liying Zhang; Sharon E Plon; Kasmintan A Schrader; Rachid Karam
Journal:  Hum Mutat       Date:  2018-11       Impact factor: 4.878

3.  Continuous Dynamic Modeling of Regulated Cell Adhesion: Sorting, Intercalation, and Involution.

Authors:  Jason M Ko; Daniel Lobo
Journal:  Biophys J       Date:  2019-10-31       Impact factor: 4.033

Review 4.  MicroRNAs and Corresponding Targets in Esophageal Cancer as Shown In Vitro and In Vivo in Preclinical Models.

Authors:  Ulrich H Weidle; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2022 Mar-Apr       Impact factor: 4.069

5.  Neonatal therapy with PF543, a sphingosine kinase 1 inhibitor, ameliorates hyperoxia-induced airway remodeling in a murine model of bronchopulmonary dysplasia.

Authors:  Alison W Ha; Tara Sudhadevi; David L Ebenezer; Panfeng Fu; Evgeny V Berdyshev; Steven J Ackerman; Viswanathan Natarajan; Anantha Harijith
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-07-22       Impact factor: 5.464

6.  Lysophosphatidic acid regulates the motility of MCF10CA1a breast cancer cell sheets via two opposing signaling pathways.

Authors:  Christina H Stuelten; Rachel M Lee; Wolfgang Losert; Carole A Parent
Journal:  Cell Signal       Date:  2018-01-11       Impact factor: 4.315

7.  Differential molecular response of larynx cancer cell lines to combined VPA/CDDP treatment.

Authors:  Ewelina Gumbarewicz; Przemko Tylżanowski; Jarogniew Łuszczki; Joanna Kałafut; Arkadiusz Czerwonka; Justyna Szumiło; Anna Wawruszak; Krzysztof Kupisz; Krzysztof Polberg; Jolanta Smok-Kalwat; Andrzej Stepulak
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

8.  Loss of the Metastasis Suppressor NME1, But Not of Its Highly Related Isoform NME2, Induces a Hybrid Epithelial-Mesenchymal State in Cancer Cells.

Authors:  Anda Huna; Béatrice Nawrocki-Raby; Teresita Padilla-Benavides; Julie Gavard; Sylvie Coscoy; David Bernard; Mathieu Boissan
Journal:  Int J Mol Sci       Date:  2021-04-02       Impact factor: 5.923

9.  A prognostic predictive model constituted with gene mutations of APC, BRCA2, CDH1, SMO, and TSC2 in colorectal cancer.

Authors:  Lei Zheng; Yang Zhan; Jia Lu; Jun Hu; Dalu Kong
Journal:  Ann Transl Med       Date:  2021-04

10.  Chick fetal organ spheroids as a model to study development and disease.

Authors:  Soran Dakhel; Wayne I L Davies; Justin V Joseph; Tushar Tomar; Silvia Remeseiro; Lena Gunhaga
Journal:  BMC Mol Cell Biol       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.